RESUMO
Objective:To investigate the nutritional risk and prevalence of malnutrition in patients with terminal stage gastrointestinal malignant tumors in a tertiary hospital in Changsha.Methods:Cluster sampling was used to conduct a cross-sectional survey of inpatients from Departments of Gastroenterology, Gastrointestinal Surgery, Hepatobiliary Surgery and Oncology in Hunan Provincial People's Hospital from January 2019 to July 2020. Nutritional Risk Screening 2002 (NRS 2002) was used to assess the prevalence of nutritional risk with malnutrition defined as concurrent presence of BMI < 18.5 kg/m 2, poor general condition and NRS 2002 nutritional impairment score of 3. Step 2 of Global Leadership Initiative on Malnutrition (GLIM) diagnostic criteria (without whole body muscle mass) was adopted to diagnose malnutrition. Step 3 of GLIM criteria was used to evaluate the prevalence of severe malnutrition. Results:A total of 802 patients registered in the 4 departments were selected for screening via cluster sampling and 514 were enrolled according to the inclusion/exclusion criteria. The prevalence of nutritional risk in patients with terminal stage gastrointestinal cancer was 49.8% (256/514). The prevalence of malnutrition and severe malnutrition per GLIM criteria were 41.6% (214/514) and 18.3% (94/514), respectively.Conclusions:Although nutritional support therapy is not recommended for patients with end-stage cancer. This paper suggests that the prevalence of nutritional risk and malnutrition in patients with end-stage gastrointestinal cancer is not as high as described in some articles.
RESUMO
Objective To observe the levels of von willebrand factor (vWF) ,antithrombin (AT) ,D‐dimer (DD) and tissue fac‐tor procoagulant activity (TF‐PCA) on patients with malignant gastrointestinal tumor and then make comparisons .Methods Use machine to detect the vWF、AT、DD and TF‐PCA levels of 50 patients with metastatic gastrointestinal malignant tumor (group C) and another 59 patients with non‐metastatic gastrointestinal malignant tumor (group B) ,and then compare them with those 60 cases of normal physical examination people (group A) .Results Compared with group A ,the levels of vWF、DD and TF‐PCA showed obvious increases (P0 .05) .Conclusion Patients with malignant gastrointestinal tumor have imbalance in coagulation and fibrinolysis system ,and this imbalance is much more obvious in metastatic tumor than non‐metastatic tumor .The prethrombotic state indexes of patients are only correlated to gas‐trointestinal malignant tumor ,but not to the parts where the tumor is in .Therefore ,the detection of vWF、AT、DD and TF‐PCA lev‐els can provide reference for the condition monitoring and prognosis of gastrointestinal malignant tumor .
RESUMO
Objective To explore 18F-FDG PET-CT in the detection of malignant tumors of the gastrointestinal tract.Methods 39 patients with gastrointestinal tumors who was diagnosed with operation,pathological examination,clinical and imaging follow-up undertake the whole-body 18F-FDG PET-CT.Results The sensitivity and specificity were both 100.0 ％ for primary malignant tumors.Gastric metastases sensitivity,specificity and accuracy were 80.0 ％ (4/5),90.9 ％ (10/11),87.5 ％ (14/16),and the colorectal metastases sensitivity,specificity,accuracy of diagnostic results were 88.9 ％ (8/9),92.9 ％ (13/14),91.3 ％ (21/23).The gastric cancer lymph node metastasis sensitivity,specificity and accuracy were 50.0 ％ (3/6),90.0 ％ (9/10),75.0 ％ (12/16),in the diagnosis of colorectal local lymph node metastasis the sensitivity,specificity and accuracy were 71.4 ％ (5/7),93.8 ％ (15/16),87.0 ％ (20/23).Conclusion The 18F-FDG PET-CT imaging for gastrointestinal malignant tumor diagnosis and residual lesions recurrence or lesions metastases of detection is of important value and better than traditional examination methods.